Related Experiment Video
Updated: Jan 31, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Antiarrhythmic Drug Therapy for Acute Management of Atrial Fibrillation and Atrial Flutter
Mohammadali Habibi1, Muhammed Rahim2, Suneet Mittal1
1Department of Cardiology, The Snyder Center for Comprehensive Atrial Fibrillation, Valley Hospital, Paramus, NJ, USA.
None:
This review outlines the pharmacologic strategies for acute management of atrial fibrillation and atrial flutter, with a focus on rate and rhythm control. It details the efficacy, indications, and safety profiles of commonly used agents, including beta-blockers, calcium channel blockers, and antiarrhythmic drugs such as amiodarone, ibutilide, dofetilide, and flecainide. The article highlights patient-specific considerations, emerging therapies, and the need for safer, faster acting drugs as atrial fibrillation prevalence rises. Both traditional and novel approaches are discussed to guide evidence-based clinical decision-making in acute settings.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Drug Therapy
Antianxiety Medications
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Acute Pyelonephritis II: Diagnostic Studies and Management

